clinical trial semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled Retatrutide vs Semaglutide: What the

Lee RH, Mara Greenberg, Metz TD, Pettker CM

20, 2025) The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S

Eur J Pharmacol 892:173721

This change in body composition could worsen insulin sensitivity

Many products contain synthetic fillers, artificial flavors, or ingredients sourced from low-quality environments

Alongside tirzepatide therapy, adopting a healthy diet, regular exercise, sufficient sleep, and routine check-ins with your provider can optimize your results